切换至 "中华医学电子期刊资源库"
高级检索
中华普通外科学文献(电子版)

中华普通外科学文献(电子版) ›› 2022, Vol. 16 ›› Issue (02) : 97 -100. doi: 10.3877/cma.j.issn.1674-0793.2022.02.002

论著

区域淋巴结清扫对肝内胆管癌根治术后复发模式的影响
郭俊标1, 李绍强1, 宋泽兵1, 黄力1, 胡文杰1,†()   
  1. 1. 510080　广州，中山大学附属第一医院肝脏外科
  • 收稿日期:2022-03-01 出版日期:2022-04-01
  • 通信作者: 胡文杰
  • 基金资助:
    国家自然科学基金资助项目(81201919，U1813204); 广东省自然科学基金资助项目(2017A030313495)

Impact of regional lymph node dissection on the recurrence pattern of intrahepatic cholangiocarcinoma after radical resection

Junbiao Guo1, Shaoqiang Li1, Zebing Song1, Li Huang1, Wenjie Hu1,†()   

  1. 1. Department of Liver Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
  • Received:2022-03-01 Published:2022-04-01
  • Corresponding author: Wenjie Hu
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

郭俊标, 李绍强, 宋泽兵, 黄力, 胡文杰. 区域淋巴结清扫对肝内胆管癌根治术后复发模式的影响[J]. 中华普通外科学文献(电子版), 2022, 16(02): 97-100.

Junbiao Guo, Shaoqiang Li, Zebing Song, Li Huang, Wenjie Hu. Impact of regional lymph node dissection on the recurrence pattern of intrahepatic cholangiocarcinoma after radical resection[J]. Chinese Archives of General Surgery(Electronic Edition), 2022, 16(02): 97-100.

目的

目前肝内胆管癌（ICC）是否常规进行区域淋巴结清扫（LND）仍存争议。本研究旨在探究LND对ICC根治术后复发模式的影响。

方法

回顾性研究中山大学附属第一医院2010年1月至2021年5月165例ICC并行LND的患者，收集患者的一般资料、血液学检查指标、术前影像学检查资料（CT、MRI或PET-CT）和手术记录，分析术前影像学诊断淋巴结转移的价值以及LND对ICC术后不同复发模式的影响。

结果

术前影像学诊断ICC淋巴结转移的敏感度为61.0%，特异度为58.9%，准确性为59.4%。124例cN0并行LND患者中，清扫个数≥6组阳性淋巴结比例占60.8%（31/51），显著高于清扫个数<6组的27.4%（20/73），差异有统计学意义（χ2=13.82，P<0.001）；随访期间，中位无复发生存时间为9.3个月（1~49.5个月），清扫个数≥6组和清扫个数<6组分别复发26、40例，清扫个数≥6组患者的局部淋巴结复发率更低，两组复发模式差异有统计学意义（P=0.037）。

结论

术前影像学诊断ICC淋巴结转移价值有限，应常规进行区域LND，清扫数量6个以上有助于改善淋巴结分期和减少cN0患者根治术后局部淋巴结复发。

关键词: 肝内胆管癌, 淋巴结清扫, 淋巴结转移, 复发模式
Objective

Routine regional lymph node dissection (LND) in the resection of intrahepatic cholangiocarcinoma (ICC) is still controversial. This study aims to investigate the impact of LND on the recurrence pattern of ICC after radical resection.

Methods

A total of 165 ICC patients from January 2010 to May 2021 in the First Affiliated Hospital of Sun Yat-sen University were retrospectively selected as the research subjects. The general information, hematological examination indexes, preoperative imaging data (CT, MRI or PET-CT) and operation records of patients were collected to analyze the impact of LND on the recurrence pattern of ICC after radical resection.

Results

The sensitivity, specificity and accuracy of preoperative imaging in diagnosing lymph node metastasis were 61.0%, 58.9% and 59.4%, respectively. Among the 124 patients with cN0 complicated with LND, the proportion of positive lymph nodes in the group with dissection ≥6 accounted for 60.8% (31/51), which was significantly higher than 27.4% (20/73) in the group with dissection <6 (χ2=13.82, P<0.001). During the follow-up period, the median recurrence free survival time was 9.3 (1-49.5) months. 26 cases recurred in the group with dissection ≥6 and 40 cases in the group dissection <6, respectively. There was significant difference in the recurrence pattern between the two groups, and the recurrence rate of regional lymph nodes in the group with dissection ≥6 was lower (P=0.037).

Conclusions

The value of preoperative imaging in diagnosing lymph node metastasis in ICC is limited, and regional LND should be performed routinely. Dissection of more than 6 lymph nodes can help to improve lymph node staging and reduce local lymph node recurrence in patients with cN0 after radical resection.

Key words: Intrahepatic cholangiocarcinoma, Lymph node dissection, Lymph node metastasis, Recurrence pattern
表1 不同清扫个数的cN0复发肝内胆管癌患者临床病理特征(例)
临床参数 清扫个数<6 清扫个数≥6 χ2值 P值
例数 40 26    
年龄(岁)     1.410 0.859
  <65 30 20    
  ≥65 10 6    
性别     0.001 0.830
  男 22 15    
  女 18 11    
癌胚抗原(μg/L)     2.607 0.337
  <5 23 18    
  ≥5 17 8    
CA19-9 (U/ml)     0.002 0.399
  <40 10 9    
  ≥40 30 17    
乙肝表面抗原     0.443 0.630
  阴性 27 19    
  阳性 13 7    
血红蛋白(g/L)     <0.001 1.000
  ≤130 20 13    
  >130 20 13    
白蛋白(g/L)     0.389 0.739
  <35 5 4    
  ≥35 35 22    
总胆红素(μmol/L)     1.879 0.027
  ≤17.1 33 15    
  >17.1 7 11    
谷丙转氨酶(U/L)     0.033 0.453
  <40 31 18    
  ≥40 9 8    
谷草转氨酶(U/L)     1.605 0.453
  <40 31 18    
  ≥40 9 8    
凝血酶原时间(s)     0.432 0.826
  <14 38 25    
  ≥14 2 1    
肿瘤大小(cm)     0.408 0.350
  <5 11 10    
  ≥5 29 16    
肿瘤个数     1.375 0.812
  1 25 17    
  >1 15 9    
出血量(ml)     0.001 0.130
  ≤300 26 12    
  >300 14 14    
输血     0.010 0.399
  无 30 17    
  有 10 9    
[1]
Kelley RK, Bridgewater J, Gores GJ, et al. Systemic therapies for intrahepatic cholangiocarcinoma[J]. J Hepatol, 2020, 72(2): 353-363.
[2]
Esnaola NF, Meyer JE, Karachristos A, et al. Evaluation and management of intrahepatic and extrahepatic cholangio-carcinoma[J]. Cancer, 2016, 122(9): 1349-1369.
[3]
Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma[J]. J Hepatol, 2014, 60(6): 1268-1289.
[4]
Mazzaferro V, Gorgen A, Roayaie S, et al. Liver resection and transplantation for intrahepatic cholangiocarcinoma[J]. J Hepatol, 2020, 72(2): 364-377.
[5]
Zhang H, Yang T, Wu M, et al. Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management[J]. Cancer Lett, 2016, 379(2): 198-205.
[6]
Guyatt GH, Oxman AD, Kunz R, et al. Going from evidence to recommendations[J]. BMJ, 2008, 336(7652): 1049-1051.
[7]
吴志平，张一帆，邓信朗,等. 肝内胆管癌根治术后生存的列线图预测模型[J/CD]. 中华普通外科学文献（电子版）, 2020, 14(2): 141-146.
[8]
Choi SB, Kim KS, Choi JY, et al. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival[J]. Ann Surg Oncol, 2009, 16(11): 3048-3056.
[9]
Lase I, Strele I, Grönberg M, et al. Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing’s syndrome[J]. Hormones (Athens), 2020, 19(3): 351-360.
[10]
Yamamoto M, Takasaki K, Otsubo T, et al. Recurrence after surgical resection of intrahepatic cholangiocarcinoma[J]. J Hepatobiliary Pancreat Surg, 2001, 8(2): 154-157.
[11]
Ke Q, Wang L, Lin Z, et al. Prognostic value of lymph node dissection for intrahepatic cholangiocarcinoma patients with clinically negative lymph node metastasis: A multi-center study from China[J]. Front Oncol, 2021, 11: 585808.
[12]
Kim DH, Choi DW, Choi SH, et al. Is there a role for systematic hepatic pedicle lymphadenectomy in intrahepatic cholangiocarcinoma? A review of 17 years of experience in a tertiary institution[J]. Surgery, 2015, 157(4): 666-675.
[13]
Sposito C, Droz Dit Busset M, Virdis M, et al. The role of lymphadenectomy in the surgical treatment of intrahepatic cholangiocarcinoma: A review[J]. Eur J Surg Oncol, 2022, 48(1): 150-159.
[14]
Morine Y, Shimada M. The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics[J]. J Gastroenterol, 2015, 50(9): 913-927.
[15]
Jiang L, Tan H, Panje CM, et al. Role of 18F-FDG PET/CT imaging in intrahepatic cholangiocarcinoma[J]. Clin Nucl Med, 2016, 41(1): 1-7.
[16]
Lee AJ, Chun YS. Intrahepatic cholangiocarcinoma: the AJCC/UICC 8th edition updates[J]. Chin Clin Oncol, 2018, 7(5): 52.
[17]
Benson AB, D’Angelica MI, Abbott DE, et al. Guidelines insights: hepatobiliary cancers, version 2. 2019[J]. J Natl Compr Canc Netw, 2019, 17(4): 302-310.
[18]
胆道肿瘤专家委员会. CSCO胆道系统肿瘤诊断治疗专家共识（2019年版）[J]. 临床肿瘤学杂志, 2019, 24(9): 828-838.
[19]
科技部传染病防治重大专项课题"病毒性肝炎相关肝癌外科综合治疗的个体化和新策略研究"专家组. 肝内胆管癌外科治疗中国专家共识（2020版） [J]. 中华消化外科杂志, 2021, 20(1): 1-15.
[20]
Kim SH, Han DH, Choi GH, et al. Extent of lymph node dissection for accurate staging in intrahepatic cholangiocarcinoma[J]. J Gastrointest Surg, 2022, 26(1): 70-76.
[21]
Chen X, Rong D, Zhang L, et al. Evaluation of nodal status in intrahepatic cholangiocarcinoma: A population-based study[J]. Ann Transl Med, 2021, 9(17): 1359.
[22]
林志文，刘红枝，曾永毅. 肝内胆管癌淋巴结清扫的热点与争议[J]. 岭南现代临床外科, 2021, 21(4): 377-382.
[23]
Weber SM, Jarnagin WR, Klimstra D, et al. Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes[J]. J Am Coll Surg, 2001, 193(4): 384-391.
[24]
Yoh T, Cauchy F, Le Roy B, et al. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study[J]. Surgery, 2019, 166(6): 975-982.
[1] 孙帼, 谢迎东, 徐超丽, 杨斌. 超声联合临床特征的列线图模型预测甲状腺乳头状癌淋巴结转移的价值[J]. 中华医学超声杂志（电子版）, 2023, 20(07): 734-742.
[2] 李素娟, 丁文波, 武心萍, 邓学东. 被膜侵犯的甲状腺微小乳头状癌发生颈部淋巴结转移的超声相关危险因素分析[J]. 中华医学超声杂志（电子版）, 2023, 20(04): 455-461.
[3] 陈启阳, 刘玉江, 刘金苹, 谭小蕖, 钱林学, 胡向东. 基于超声造影的预测模型对甲状腺乳头状癌颈中央区淋巴结转移的诊断价值[J]. 中华医学超声杂志（电子版）, 2023, 20(04): 442-448.
[4] 刘星辰, 刘娟, 魏宝宝, 刘洁, 刘辉. XIAP与XAF1异常表达与卵巢癌的相关性分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 419-427.
[5] 李雄雄, 周灿, 徐婷, 任予, 尚进. 初诊导管原位癌伴微浸润腋窝淋巴结转移率的Meta分析[J]. 中华普通外科学文献(电子版), 2023, 17(06): 466-474.
[6] 樊逸隽, 杨枫, 王玮, 殷鹤英, 刘俊. 喉前淋巴结转移对甲状腺乳头状癌诊疗价值的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(04): 306-310.
[7] 杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[8] 燕速, 霍博文, 徐惠宁. 4K荧光腹腔镜扩大右半结肠CME+D3根治术及No.206、No.204组淋巴结清扫术[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 14-14.
[9] 袁育韬, 邢金琳, 谢克飞, 殷凯. CT征象及BRAFV600E基因突变与甲状腺乳头状癌中央区淋巴结转移的相关性[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 611-614.
[10] 徐成, 王璐璐, 王少华. 洗脱液甲状腺球蛋白在甲状腺乳头状癌转移淋巴结中的应用[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 701-704.
[11] 燕速. 腹腔镜低位直肠癌盆腔侧方淋巴结清扫指征与策略[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 480-484.
[12] 屈洪波, 朱芳, 徐喆, 武楠, 何建怀, 王先明. 经肌间入路行锁骨下淋巴结清扫在局部晚期乳腺癌中的应用[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 510-513.
[13] 李子禹, 高翔宇. 根治性全胃切除术Roux-en-Y π形吻合[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 372-372.
[14] 潘冰, 吕少诚, 赵昕, 李立新, 郎韧, 贺强. 淋巴结清扫数目对远端胆管癌胰十二指肠切除手术疗效的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 608-612.
[15] 廖承煜, 江斌华, 黄龙, 王丹凤, 田毅峰, 陈实. 腹腔镜下肝左叶肝内胆管细胞癌根治术优化三步法的应用价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 395-400.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号